Evidence map›Paper›PMID 40771009›Full record

ArticleCancer science2025

Allelic Imbalance and Chromothripsis Lead to Diversity in Japanese Tumor Genomes With Whole-Genome Duplication.

Keiichi Hatakeyama, Takeshi Nagashima, Sumiko Ohnami, Shumpei Ohnami, Koji Maruyama, Keiichi Ohshima, Yuji Shimoda, Akane Naruoka, Hirotsugu Kenmotsu, Kenichi Urakami and 2 more

Abstract read
In one paragraph

Article in Cancer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Keiichi HatakeyamaCancer Multiomics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID https://orcid.org/0000-0001-6000-5899
Takeshi NagashimaCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID https://orcid.org/0000-0002-7261-9908
Sumiko OhnamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Shumpei OhnamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Koji MaruyamaExperimental Animal Facility, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Keiichi OhshimaMedical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID https://orcid.org/0000-0002-2882-7566
Yuji ShimodaCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Akane NaruokaDrug Discovery and Development Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID https://orcid.org/0000-0002-6401-0318
Hirotsugu KenmotsuDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.ORCID https://orcid.org/0000-0003-0590-9259
Kenichi UrakamiCancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
Yasuto AkiyamaImmunotheraphy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.ORCID https://orcid.org/0000-0003-3813-7726
Ken YamaguchiShizuoka Cancer Center, Shizuoka, Japan.

Funding

Japan Agency for Medical Research and Development JP22k0106689
6 · The paper itself

Abstract

Whole-genome analyses have revealed that large-scale structural variations (SVs) such as whole-genome duplication (WGD) occur early in the development of many cancers. However, the diversity of chromosomal abnormalities within tumors before and after WGD remains poorly understood. Here, we analyzed various types of Japanese tumor genomes via whole-genome sequencing and examined the diversity of WGD by focusing on large SVs at the chromosomal level. WGD was detected in 52% of cases, while the frequency of chromothripsis (CT) was 20%. Although aneuploidy via deletion of chromosome arms was common in many cancers, in rare ovarian cancers, all chromosomes were near-haploidy before WGD. Minor allele analysis revealed that many non-mutated ohnolog genes drifted down chromosome arms after WGD and returned to normal ploidy, but only 17p, including TP53, which is also an ohnolog, underwent loss of heterozygosity due to arm deletion before WGD in most cancers. TP53 mutations were frequently detected in WGD and CT-positive tumors, and these SVs strongly correlated with homologous recombination deficiency scores. Furthermore, these tumors had many mutations that continued to generate neoantigens and resulted in worse survival outcomes. Diversity analysis of tumors with WGD will provide a new perspective on structural abnormalities in tumor genomes.

Indexed as

Allelic ImbalanceChromothripsisGenome, HumanNeoplasmsAneuploidyEast Asian PeopleFemaleGene DuplicationHumansJapanLoss of HeterozygosityMutationTumor Suppressor Protein p53Whole Genome SequencingTumor Suppressor Protein p53aneuploidychromothripsispotentially neoantigen‐generative structural variationstructural variationwhole‐genome duplication

Identifiers

PMID40771009
PMCPMC12485667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.